ES2675018T3 - Sodium Reduced Food Products - Google Patents

Sodium Reduced Food Products Download PDF

Info

Publication number
ES2675018T3
ES2675018T3 ES14705945.5T ES14705945T ES2675018T3 ES 2675018 T3 ES2675018 T3 ES 2675018T3 ES 14705945 T ES14705945 T ES 14705945T ES 2675018 T3 ES2675018 T3 ES 2675018T3
Authority
ES
Spain
Prior art keywords
ppm
compound
compounds
use according
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14705945.5T
Other languages
Spanish (es)
Inventor
Bernhard H. Van Lengerich
Olaf Gruess
Joachim Hans
Lars Ole HAUSTEDT
Andreas HOCHHEIMER
Micheal Krohn
Jens-Peter Muller
Christine M. Nowakowski
Suzanne Denise PECORE
Candace Michelle RATHJEN-NOWAK
Lia SCARABOTTOLO
Karsten Siems
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Mills Inc
Original Assignee
General Mills Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Mills Inc filed Critical General Mills Inc
Application granted granted Critical
Publication of ES2675018T3 publication Critical patent/ES2675018T3/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L23/00Soups; Sauces; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/40Table salts; Dietetic salt substitutes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/40Table salts; Dietetic salt substitutes
    • A23L27/45Salt substitutes completely devoid of sodium chloride
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/117Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Seasonings (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Grain Derivatives (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)

Abstract

El uso de por lo menos un compuesto (a) que se sintetiza o deriva de un producto natural y se selecciona del grupo que consiste en los siguientes compuestos:**Fórmula** en el que el compuesto (a) se separa de su medio natural si se deriva de un producto natural, para sustituir al cloruro de sodio en una sopa.The use of at least one compound (a) that is synthesized or derived from a natural product and is selected from the group consisting of the following compounds: ** Formula ** in which the compound (a) separates from its medium natural if derived from a natural product, to replace sodium chloride in a soup.

Description

55

1010

15fifteen

20twenty

2525

3030

3535

4040

45Four. Five

50fifty

5555

6060

6565

DESCRIPCIONDESCRIPTION

Productos alimenticios reducidos en sodio CAMPOSodium reduced food products FIELD

Esta invención se refiere al uso de ciertos compuestos para sustituir cloruro de sodio en una sopa.This invention relates to the use of certain compounds to substitute sodium chloride in a soup.

ANTECEDENTESBACKGROUND

El cloruro de sodio, sal de mesa ordinaria, es el compuesto prototípico para provocar la percepción del sabor salado. Sin embargo, los intentos de reducir el consumo de sodio han conducido a los investigadores a encontrar sustitutos apropiados para el cloruro de sodio o a reducir las cantidades de cloruro de sodio, sin sacrificar el sabor salado.Sodium chloride, ordinary table salt, is the prototypic compound to cause the perception of salty taste. However, attempts to reduce sodium intake have led researchers to find appropriate substitutes for sodium chloride or to reduce the amounts of sodium chloride, without sacrificing the salty taste.

Las sales pueden provocar sabores complejos, que incluyen mezclas de componentes de percepción dulces, amargos, agrios, umami y salados. Se cree que los cationes de sales imparten el componente de percepción de sabor, mientras que los aniones, además de contribuir a los sabores propios, modifican la percepción del sabor de los cationes. A modo de ejemplo, se cree que el sodio y el litio imparten solo sabores salados, mientras que el potasio y otros cationes alcalinotérreos producen sabores tanto salados como amargos. Entre los aniones que se encuentran comúnmente en los alimentos, el ion cloruro se considera el menos inhibidor del sabor salado, mientras que el anión citrato es más inhibidor.Salts can cause complex flavors, including mixtures of sweet, sour, sour, umami and salty perception components. It is believed that the salt cations impart the flavor perception component, while the anions, in addition to contributing to their own flavors, modify the perception of the flavor of the cations. As an example, it is believed that sodium and lithium impart only salty flavors, while potassium and other alkaline earth cations produce both salty and bitter flavors. Among the anions that are commonly found in foods, the chloride ion is considered the least salty taste inhibitor, while the citrate anion is more inhibitor.

Se han realizado muchos intentos para proporcionar composiciones de sabor salado como un sustituto de la sal de mesa que dará el mismo o un efecto de condimento similar y que están compuestas por cantidades sustancialmente reducidas de cloruro de sodio. Con este fin, se han sugerido cloruro de potasio, cloruro de amonio y compuestos similares. El uso de tales sales, y combinaciones de tales sales, deja mucho que desear en cuanto al sabor. Ninguno de ellos individualmente o en combinación afecta positivamente a otras modalidades de sabor y sabe a cloruro de sodio. Cada uno solo tiene un sabor desagradable, al igual que las mezclas de tales sales. Por ejemplo, el cloruro de potasio tiene un fuerte regusto que es caracterizado como "amargo" por la mayoría de las personas. El cloruro de amonio también tiene un regusto amargo.Many attempts have been made to provide salty flavor compositions as a substitute for table salt that will give the same or a similar seasoning effect and that are composed of substantially reduced amounts of sodium chloride. To this end, potassium chloride, ammonium chloride and similar compounds have been suggested. The use of such salts, and combinations of such salts, leaves much to be desired in terms of taste. None of them individually or in combination positively affects other taste modalities and tastes like sodium chloride. Each has only an unpleasant taste, as do mixtures of such salts. For example, potassium chloride has a strong aftertaste that is characterized as "bitter" by most people. Ammonium Chloride also has a bitter aftertaste.

SUMARIOSUMMARY

Esta descripción describe, entre otras cosas, compuestos que provocan o mejoran la percepción del sabor salado, u otro sabor complejo asociado con el consumo de cloruro sódico, o que interactúan con un receptor o canal iónico asociado con la percepción de salado sabor u otro sabor complejo asociado con el consumo de cloruro de sodio. En realizaciones, los compuestos bioactivos son compuestos moduladores del sabor usados como ingredientes en productos alimenticios para provocar o mejorar la percepción del sabor salado. En realizaciones, los productos alimentarios contienen cantidades de sodio menores de lo normal. Preferentemente, los compuestos moduladores del sabor son compuestos bioactivos capaces de ser derivados de productos naturales.This description describes, among other things, compounds that cause or improve the perception of salty taste, or other complex flavor associated with the consumption of sodium chloride, or that interact with a receptor or ion channel associated with the perception of salty taste or other flavor. complex associated with the consumption of sodium chloride. In embodiments, bioactive compounds are flavor modulating compounds used as ingredients in food products to cause or improve the perception of salty taste. In embodiments, food products contain lower than normal amounts of sodium. Preferably, flavor modulating compounds are bioactive compounds capable of being derived from natural products.

Según esta invención, por lo menos un compuesto seleccionado de entre los compuestos (10), (12), (13), (16), (29), (33), (36), (37), (41), (43), (44), (45), (48), (53), (56), (66), (73), (82), (83), y (84) descritos a continuación se usa para sustituir el cloruro de sodio en una sopa.According to this invention, at least one compound selected from among the compounds (10), (12), (13), (16), (29), (33), (36), (37), (41), (43), (44), (45), (48), (53), (56), (66), (73), (82), (83), and (84) described below are used to Replace the sodium chloride in a soup.

Una o más realizaciones de los compuestos, composiciones, productos alimentarios o métodos descritos aquí proporcionan una o más ventajas sobre los compuestos, composiciones, productos alimenticios o métodos anteriores. Por ejemplo, los productos alimentarios que incluyen uno o más compuestos salados o que modulan el sabor descritos aquí pueden tener un menor contenido de sodio en relación con los productos alimentarios que no incluyen dichos compuestos salados o moduladores del sabor mientras imparten un nivel similar de salinidad. Esta y otras ventajas se entenderán fácilmente a partir de la siguiente descripción detallada.One or more embodiments of the compounds, compositions, food products or methods described herein provide one or more advantages over the above compounds, compositions, food products or methods. For example, food products that include one or more salty compounds or that modulate the taste described herein may have a lower sodium content in relation to food products that do not include such salty compounds or flavor modulators while imparting a similar level of salinity . This and other advantages will be easily understood from the following detailed description.

BREVE DESCRIPCIÓN DE LOS DIBUJOSBRIEF DESCRIPTION OF THE DRAWINGS

La FIGURA 1 es una tabla que proporciona resultados de la prueba de puntuación del DAP con respecto a la percepción de la salinidad de varias combinaciones de compuestos en disolución de cloruro de sodio.FIGURE 1 is a table that provides results of the DAP scoring test with respect to the salinity perception of various combinations of compounds in sodium chloride solution.

La FIGURA 2 es una tabla que proporciona resultados de la prueba de puntuación del DAP con respecto a la percepción de la salinidad de varias combinaciones de compuestos en combinación en disolución de caldo.FIGURE 2 is a table that provides DAP score test results regarding the salinity perception of various combinations of compounds in combination in broth solution.

DESCRIPCIÓN DETALLADADETAILED DESCRIPTION

La presente invención se refiere al uso de por lo menos un compuesto seleccionado de entre los compuestos (10), (12), (13), (16), (29), (33), (36), (37), (41), (43), (44), (45), (48), (53), (56), (66), (73), (82), (83),y (84) descritos a continuación para sustituir el cloruro de sodio en una sopa.The present invention relates to the use of at least one compound selected from among the compounds (10), (12), (13), (16), (29), (33), (36), (37), (41), (43), (44), (45), (48), (53), (56), (66), (73), (82), (83), and (84) described a then to replace the sodium chloride in a soup.

Todos los términos científicos y técnicos usados aquí tienen significados comúnmente usados en la técnica, a menos que se especifique lo contrario. Las definiciones proporcionadas aquí son para facilitar la comprensión de ciertos términos usados con frecuencia aquí y no se pretende que limiten el alcance de la presente descripción.All scientific and technical terms used here have meanings commonly used in the art, unless otherwise specified. The definitions provided here are to facilitate the understanding of certain terms frequently used here and are not intended to limit the scope of this description.

Tal como se usa en esta memoria descriptiva y en las reivindicaciones adjuntas, las formas en singular "un", "una" yAs used herein and in the appended claims, the singular forms "a", "a" and

55

1010

15fifteen

20twenty

2525

3030

3535

4040

45Four. Five

50fifty

5555

6060

6565

"el" incluyen realizaciones que tiene referentes plurales, a menos que el contenido indique claramente lo contrario."el" includes embodiments that have plural referents, unless the content clearly indicates otherwise.

Tal como se usa en esta memoria descriptiva y en las reivindicaciones adjuntas, el término "o" se emplea generalmente en su sentido que incluye "y/o" a menos que el contenido indique claramente lo contrario. El término "y/o" quiere decir uno o todos los elementos enumerados o una combinación de dos o más de los elementos enumerados.As used herein and in the appended claims, the term "or" is generally used in its sense that includes "and / or" unless the content clearly indicates otherwise. The term "and / or" means one or all of the items listed or a combination of two or more of the items listed.

Tal como se usa aquí, "tiene", "que tiene", "incluye", "que incluye", "comprende", "que comprende" o similares se usan en su sentido abierto, y generalmente quiere decir "que incluye, pero no limitado a". Se entenderá que "que consiste esencialmente en", "que consiste en", y similares se incluyen en "que comprende "y similares. Tal como se usa aquí, "que consiste esencialmente en", en lo que se refiere a una composición, producto, método o similares, quiere decir que los componentes de la composición, producto, método o similares están limitados a los componentes enumerados y cualquier otro componente que no afecte materialmente a la(s) característica(s) básica(s) y nueva(s) de la composición, producto, método o similares.As used herein, "it has", "it has", "it includes", "it includes", "it includes", "it comprises" or the like is used in its open sense, and it generally means "that includes, but not limited to ". It will be understood that "consisting essentially of", "consisting of", and the like are included in "comprising" and the like. As used herein, "consisting essentially of", as regards a composition, product, method or the like, it means that the components of the composition, product, method or the like are limited to the listed components and any another component that does not materially affect the basic (s) and new (s) characteristic (s) of the composition, product, method or the like.

Las palabras "preferido" y "preferentemente" se refieren a realizaciones de la invención que pueden proporcionar ciertos beneficios, en ciertas circunstancias. Sin embargo, también se pueden preferir otras realizaciones, en las mismas u otras circunstancias. Además, la citación de una o más realizaciones preferidas no implica que otras realizaciones no sean útiles, y no se pretende excluir otras realizaciones del alcance de la descripción, incluyendo las reivindicaciones.The words "preferred" and "preferably" refer to embodiments of the invention that may provide certain benefits, in certain circumstances. However, other embodiments may also be preferred, in the same or other circumstances. In addition, the citation of one or more preferred embodiments does not imply that other embodiments are not useful, and it is not intended to exclude other embodiments from the scope of the description, including the claims.

También aquí, las citaciones de intervalos numéricos por puntos finales incluyen todos los números incluidos dentro de ese intervalo (por ejemplo, de 1 a 5 incluye 1, 1,5, 2, 2,75, 3, 3,80, 4, 5, etc. o 10 o menos incluye 10, 9,4, 7,6, 5, 4,3, 2,9, 1,62, 0,3, etc.). Cuando un intervalo de valores es "hasta" un valor particular, ese valor se incluye dentro del intervalo.Also here, citations of numerical intervals by endpoints include all numbers included within that range (for example, 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, 5 , etc. or 10 or less includes 10, 9.4, 7.6, 5, 4.3, 2.9, 1.62, 0.3, etc.). When a range of values is "up to" a particular value, that value is included within the range.

Tal como se usa aquí, un “producto alimentario” es un alimento producido mezclando dos o más ingredientes comestibles.As used herein, a "food product" is a food produced by mixing two or more edible ingredients.

Tal como se usa aquí, un "compuesto bioactivo" es un compuesto que interacciona con un receptor o canal iónico asociado con la percepción del sabor salado u otro sabor asociado con el consumo de cloruro de sodio.As used herein, a "bioactive compound" is a compound that interacts with an ionic receptor or channel associated with the perception of salty taste or other flavor associated with the consumption of sodium chloride.

Tal como se usa aquí, un "compuesto modulador del sabor" es un compuesto que modifica el sabor de un producto alimentario. A modo de ejemplo, un compuesto modulador del sabor puede modificar el sabor de un producto alimentario debido a un sabor particular impartido por el compuesto modulador del sabor, debido a una modificación del sabor percibido del producto alimentario, o uno de sus componente, o similares. En realizaciones, un compuesto modulador del sabor es un compuesto modulador del sabor salado.As used herein, a "flavor modulator compound" is a compound that modifies the taste of a food product. By way of example, a flavor modulating compound may modify the taste of a food product due to a particular taste imparted by the flavor modulating compound, due to a modification of the perceived taste of the food product, or one of its components, or the like. . In embodiments, a flavor modulator compound is a salt flavor modulator compound.

Tal como se usa aquí, un "compuesto modulador del sabor salado" es un compuesto que, cuando se ingiere, (i) provoca o potencia una percepción del sabor salado solo o en presencia de una sal, tal como cloruro de sodio o (ii) altera el flujo de iones a través de uno o más canales iónicos asociados con la percepción del sabor salado. Los ejemplos de canales iónicos asociados a la percepción del sabor salado incluyen el canal ENaC, el canal TrpV1, y el canal TrpML3.As used herein, a "salty taste modulating compound" is a compound that, when ingested, (i) causes or enhances a perception of salty taste alone or in the presence of a salt, such as sodium chloride or (ii ) alters the flow of ions through one or more ion channels associated with the perception of salty taste. Examples of ion channels associated with the perception of salty taste include the ENaC channel, the TrpV1 channel, and the TrpML3 channel.

Tal como se usa aquí, un compuesto "derivado" de un producto natural es un compuesto que existe en un producto natural, cuya identidad se verifica. Un compuesto sintetizado puede ser un compuesto derivado de un producto natural, con tal de que el compuesto sintetizado sea un compuesto que existe en el producto natural.As used herein, a compound "derived" from a natural product is a compound that exists in a natural product, whose identity is verified. A synthesized compound can be a compound derived from a natural product, as long as the synthesized compound is a compound that exists in the natural product.

Tal como se usa aquí, un compuesto "aislado" o "purificado" es un compuesto que se separa sustancialmente de otros componentes de la fuente del compuesto. Por ejemplo, si la fuente del compuesto es un producto natural, un compuesto aislado o purificado puede ser un compuesto que se separa de su medio natural. Si el compuesto es sintetizado, el compuesto se puede separar de los reactivos, subproductos de reacción, disolventes o similares sin reaccionar.As used herein, an "isolated" or "purified" compound is a compound that is substantially separated from other components of the source of the compound. For example, if the source of the compound is a natural product, an isolated or purified compound may be a compound that separates from its natural environment. If the compound is synthesized, the compound can be separated from unreacted reagents, reaction by-products, solvents or the like.

En realizaciones, una composición que incluye un compuesto modulador del sabor salado se percibe como que imparte una cantidad de salinidad igual a una composición sustancialmente similar que no incluye el compuesto modulador del sabor salado pero que tiene una mayor concentración de la sal. Preferentemente, la composición que incluye el compuesto modulador del sabor salado imparte una percepción de salinidad igual a la composición sustancialmente similar que no tiene el compuesto modulador del sabor salado cuando la composición tiene alrededor de 1% o menos sal que la composición sustancialmente similar. Por ejemplo, la composición que incluye el compuesto modulador del sabor salado puede impartir una percepción de salinidad igual a la composición sustancialmente similar que no tiene el compuesto salado cuando la composición tiene alrededor de 2% o menos, alrededor de 5% o menos, alrededor de 7% o menos, alrededor de 8% o menos, alrededor de 9% o menos, alrededor de 10% o menos, alrededor de 11% o menos, alrededor de 15% o menos, alrededor de 20% o menos, alrededor de 30% o menos, alrededor de 35% o menos, alrededor de 40% o menos, o alrededor de 50% o menosIn embodiments, a composition that includes a salt flavor modulator compound is perceived as imparting an amount of salinity equal to a substantially similar composition that does not include the salt flavor modulator compound but has a higher salt concentration. Preferably, the composition that includes the salty taste modulating compound imparts a perception of salinity equal to the substantially similar composition that the salty flavor modulating compound does not have when the composition has about 1% or less salt than the substantially similar composition. For example, the composition that includes the salty taste modulating compound may impart a salinity perception equal to the substantially similar composition that the salty compound does not have when the composition is about 2% or less, about 5% or less, about 7% or less, about 8% or less, about 9% or less, about 10% or less, about 11% or less, about 15% or less, about 20% or less, about 30% or less, about 35% or less, about 40% or less, or about 50% or less

55

1010

15fifteen

20twenty

2525

3030

3535

4040

45Four. Five

50fifty

5555

6060

que la composición sustancialmente similar. En otras palabras, uno o más compuestos moduladores del sabor salado pueden estar presentes en un producto alimentario en una cantidad suficiente para reducir la cantidad de una sal, tal como cloruro de sodio, en alrededor de 1% o más, alrededor de 2% o más, alrededor de 5% o más, alrededor de 7% o más, alrededor de 8% o más, alrededor de 10% o más, alrededor de 11% o más, alrededor de 12% o más, alrededor de 15% o más, alrededor de 20% o más, alrededor de 22% o más, alrededor de 25% o más, alrededor de 30% o más, alrededor de 35% o más, alrededor de 40% o más, alrededor de 45% o más, alrededor de 50% o más, alrededor de 55% o más, alrededor de 60% o más, alrededor de 65% o más, alrededor de 70% o más, alrededor de 75% o más, alrededor de 80% o más, alrededor de 85% o más, alrededor de 90% o más, alrededor de 95% o más, o similares. El producto alimentario reducido en sal provoca la misma o similar percepción de la salinidad que un producto alimentario sustancialmente similar que no incluye uno o más compuestos moduladores del sabor salado.than the substantially similar composition. In other words, one or more salt flavor modulating compounds may be present in a food product in an amount sufficient to reduce the amount of a salt, such as sodium chloride, by about 1% or more, about 2% or more, about 5% or more, about 7% or more, about 8% or more, about 10% or more, about 11% or more, about 12% or more, about 15% or more , about 20% or more, about 22% or more, about 25% or more, about 30% or more, about 35% or more, about 40% or more, about 45% or more, about 50% or more, about 55% or more, about 60% or more, about 65% or more, about 70% or more, about 75% or more, about 80% or more, about 85% or more, about 90% or more, about 95% or more, or the like. The reduced salt food product causes the same or similar perception of salinity as a substantially similar food product that does not include one or more salty flavor modulating compounds.

La percepción de salinidad se puede evaluar de cualquier manera apropiada. En realizaciones, la salinidad se determina por un panel sensorial analítico entrenado. En realizaciones, el panel sensorial entrenado determina la salinidad de una composición que tiene un compuesto modulador del sabor salado con relación a una composición sustancialmente similar que tiene un contenido de cloruro sódico incrementado si un panel analítico sensorial entrenado determina primero que la composición y la composición sustancialmente similar solo difieren en sabor respecto a la salinidad.The perception of salinity can be evaluated in any appropriate way. In embodiments, salinity is determined by a trained analytical sensory panel. In embodiments, the trained sensory panel determines the salinity of a composition that has a salty taste modulating compound relative to a substantially similar composition that has an increased sodium chloride content if a trained sensory analytical panel first determines that the composition and composition substantially similar only differ in taste with respect to salinity.

Un compuesto modulador del sabor salado puede ser un compuesto que directamente actúa para provocar o mejorar la percepción del sabor salado de una sal o puede ser un compuesto que se convierte, cuando se ingiere, en un compuesto que actúa directamente para provocar la mejora de la percepción del sabor salado de la sal.A salty taste modulating compound can be a compound that directly acts to cause or improve the perception of the salty taste of a salt or it can be a compound that becomes, when ingested, a compound that acts directly to cause the improvement of perception of the salty taste of salt.

Para los propósitos de esta descripción, la referencia a un compuesto incluye la referencia a sales del compuesto, hidratos del compuesto, polimorfos del compuesto, isómeros del compuesto (incluyendo isómeros constitucionales y estereoisómeros tales como enantiómeros y diasterómeros) y similares.For the purposes of this description, reference to a compound includes reference to salts of the compound, hydrates of the compound, polymorphs of the compound, isomers of the compound (including constitutional isomers and stereoisomers such as enantiomers and diastereomers) and the like.

Tal como se usa aquí, una composición que es "sustancialmente similar" a otra composición contiene sustancialmente la misma concentración de componentes (por ejemplo, dentro de alrededor de 5%) a excepción de los componentes específicamente enumerados que hacen las composiciones diferentes. Por ejemplo, una composición que incluye un compuesto salado puede ser sustancialmente similar a una composición que no tiene el compuesto salado, si los componentes de las composiciones, aparte de la sal y el compuesto salado, están presentes en una concentración sustancialmente similarAs used herein, a composition that is "substantially similar" to another composition contains substantially the same concentration of components (for example, within about 5%) except for the specifically listed components that make the different compositions. For example, a composition that includes a salted compound may be substantially similar to a composition that does not have the salted compound, if the components of the compositions, apart from the salt and the salted compound, are present in a substantially similar concentration

Tal como se usa aquí, un compuesto bioactivo, modulador del sabor o modulador del sabor salado que se deriva de un "producto natural” es un compuesto que se extrae de, por ejemplo, una fuente vegetal o microbiana en contraposición a ser producido sintéticamente. La extracción o aislamiento del compuesto bioactivo modulador del sabor, modulador del sabor salado de origen natural se puede facilitar mediante reacciones químicas simples tales como acidificación, basificación, intercambio iónico, hidrólisis y formación de sal, así como fermentación microbiana y similares. En realizaciones, un compuesto bioactivo, modulador del sabor, o modulador del sabor salado se deriva de fuentes naturales tales como plantas, hongos y fuentes bacterianas. Los ejemplos de tales fuentes naturales incluyen, pero no se limitan a, Aesculus hippocastaneum; Alchemilla xanthochlora; Angelica archangelica; Apocynum cannabinum; Azadirachta indica; Bacteria Actinomycete (código de cepa: 01702axxx000002); Capsicum annuum; Cimicifuga racemosa; Commiphora mukul; Embelia ribes; Evodia rutaecarpa; Ferula assa-foetida; Hongos (Código de cepa: 02295fxxx000001; Código de cepa: 01469fxxx000005); Gleditschia australis; Kaempferia galanga; Lavandula officinalis; Marrubium vulgare; Mesua ferrea; Nephelium cuspidatum; Orthosiphon stamineus; Persea gratissima; Petroselinum stativum; Piper longum; Pithecoctenium echinatum; Podophyllum peltatum; Psidium guajava; Ricinus communis; Salviamiltiorrhiza; Schisandea chinensis; Teclea trichocarpa; Vitex agnus; Xysmalobium undulatum; Yucca gloriosa; Zanthoxylumpiperitum; Zingiber officinalis; y otros. En realizaciones, uno o más compuestos derivados de Persea gratissima se combinan con uno o más compuestos derivados de Kaempferia galanga o uno o más compuestos derivados de Capsicum annuum; y otros.As used herein, a bioactive compound, flavor modulator or salt flavor modulator that is derived from a "natural product" is a compound that is extracted from, for example, a plant or microbial source as opposed to being synthetically produced. The extraction or isolation of the bioactive compound that modulates flavor, modulates the salty flavor of natural origin can be facilitated by simple chemical reactions such as acidification, basification, ion exchange, hydrolysis and salt formation, as well as microbial fermentation and the like. a bioactive compound, flavor modulator, or salty taste modulator is derived from natural sources such as plants, fungi and bacterial sources.Examples of such natural sources include, but are not limited to, Aesculus hippocastaneum; Alchemilla xanthochlora; Angelica archangelica; Apocynum cannabinum; Azadirachta indica; Actinomycete bacteria (strain code: 01702axxx0000 02); Capsicum annuum; Cimicifuga racemosa; Commiphora mukul; Embelia ribes; Evodia rutaecarpa; Ferula assa-foetida; Fungi (strain code: 02295fxxx000001; strain code: 01469fxxx000005); Gleditschia australis; Kaempferia galanga; Lavandula officinalis; Marrubium vulgare; Mesua iron; Nephelium cuspidatum; Orthosiphon stamineus; Persea gratissima; Petroselinum stativum; Piper longum; Pithecoctenium echinatum; Podophyllum peltatum; Psidium guajava; Ricinus communis; Salviamiltiorrhiza; Schisandea chinensis; Type trichocarpa; Vitex agnus; Xysmalobium undulatum; Glorious Yucca; Zanthoxylumpiperitum; Zingiber officinalis; and others. In embodiments, one or more compounds derived from Persea gratissima are combined with one or more compounds derived from Kaempferia galanga or one or more compounds derived from Capsicum annuum; and others.

COMPUESTOS BIOACTIVOS MODULADORES DEL SABOR, Y MODULADORES DEL SABOR SALADO Se presentan aquí compuestos de origen natural que se ha identificado que provocan o mejoran la percepción de salinidad, y clases de compuestos derivados de ellos.BIOACTIVE COMPOUNDS MODULATORS OF FLAVOR, AND MODULATORS OF SALT FLAVOR Compounds of natural origin that have been identified that cause or improve the perception of salinity, and classes of compounds derived from them are presented here.

En realizaciones, un compuesto bioactivo, modulador del sabor, o modulador del sabor salado es un compuesto que tiene la siguiente estructura (A) que no está incluida en las reivindicacionesIn embodiments, a bioactive compound, flavor modulator, or salty taste modulator is a compound having the following structure (A) that is not included in the claims

en la que:in which:

imagen1image 1

55

1010

15fifteen

20twenty

2525

3030

R1 es H o alquilo de C1-C10;R1 is H or C1-C10 alkyl;

R2 es H o alquilo de C1-C3;R2 is H or C1-C3 alkyl;

X es CHOR3 o C=O;X is CHOR3 or C = O;

R3 es H o alquilo de C1-C3; oR3 is H or C1-C3 alkyl; or

OOR

--------C-------R4--------- C ------- R4-

R4 es H o alquilo de C1-C3;R4 is H or C1-C3 alkyl;

Y es CR5=CH o CHR5-CH2;Y is CR5 = CH or CHR5-CH2;

R5 es H, OH, -OCH3, -OCH2CH3, -O-OCH2CH2CH3, oR5 is H, OH, -OCH3, -OCH2CH3, -O-OCH2CH2CH3, or

OOR

--------O-------C-------R6;-------- OR ------- C ------- R6;

y 6and 6

R6 es H o alquiloR6 is H or alkyl

de C1-C6.of C1-C6.

En realizaciones, R1 esIn embodiments, R1 is

alquilo de C2-C8. En realizaciones, R2 es H. En realizaciones, X es C=O oC2-C8 alkyl. In embodiments, R2 is H. In embodiments, X is C = O or

oor

imagen2image2

en la que R4 es CH3. En realizaciones, cuando Y es CR5=CH, R5 es H. En realizaciones, cuando Y es CHR5-CH2, R5 es OH o -OCH3. En realizaciones, R6 es CH3.in which R4 is CH3. In embodiments, when Y is CR5 = CH, R5 is H. In embodiments, when Y is CHR5-CH2, R5 is OH or -OCH3. In embodiments, R6 is CH3.

En realizaciones, un compuesto bioactivo, modulador del sabor, o modulador del sabor salado es un compuesto que tiene una o más de las siguientes estructuras (que no están incluidas en las reivindicaciones):In embodiments, a bioactive compound, flavor modulator, or salty taste modulator is a compound that has one or more of the following structures (which are not included in the claims):

imagen3image3

imagen4image4

Claims (19)

REIVINDICACIONES 1. El uso de por lo menos un compuesto (a) que se sintetiza o deriva de un producto natural y se selecciona del grupo que consiste en los siguientes compuestos:1. The use of at least one compound (a) that is synthesized or derived from a natural product and is selected from the group consisting of the following compounds: imagen1image 1 1010 oor imagen2image2 (16)(16) imagen3image3 55 imagen4image4 imagen5image5 imagen6image6 (44)(44) imagen7image7 55 imagen8image8 55 1010 15fifteen 20twenty 2525 3030 imagen9image9 oor imagen10image10 en el que el compuesto (a) se separa de su medio natural si se deriva de un producto natural, para sustituir al cloruro de sodio en una sopa.in which the compound (a) is separated from its natural environment if it is derived from a natural product, to replace the sodium chloride in a soup. 2. El uso según la reivindicación 1, en el que se usan por lo menos dos compuestos seleccionados del grupo que consiste en los compuestos (10), (12), (13), (16), (29), (33), (36), (37), (41), (43), (44), (45), (48), (53), (56), (62), (66), (73), (82), (83) y (84) mostrados en la reivindicación 1.2. The use according to claim 1, wherein at least two compounds selected from the group consisting of the compounds (10), (12), (13), (16), (29), (33) are used , (36), (37), (41), (43), (44), (45), (48), (53), (56), (62), (66), (73), ( 82), (83) and (84) shown in claim 1. 3. El uso según la reivindicación 1, en el que se usan por lo menos tres compuestos seleccionados del grupo que consiste en los compuestos (10), (12), (13), (16), (29), (33), (36), (37), (41), (43), (44), (45), (48), (53), (56), (62), (66), (73), (82), (83) y (84) mostrados en la reivindicación 1.3. The use according to claim 1, wherein at least three compounds selected from the group consisting of the compounds (10), (12), (13), (16), (29), (33) are used , (36), (37), (41), (43), (44), (45), (48), (53), (56), (62), (66), (73), ( 82), (83) and (84) shown in claim 1. 4. El uso según la reivindicación 1, en el que se usan por lo menos dos compuestos seleccionados del grupo que consiste en los compuestos (10), (12), (13), (36), (45), (56), (82) y (83) mostrados en la reivindicación 1.4. The use according to claim 1, wherein at least two compounds selected from the group consisting of the compounds (10), (12), (13), (36), (45), (56) are used , (82) and (83) shown in claim 1. 5. El uso según la reivindicación 1, en el que se usan por lo menos tres compuestos seleccionados del grupo que consiste en los compuestos (10), (12), (13), (36), (45), (56), (82) y (83) mostrados en la reivindicación 1.5. The use according to claim 1, wherein at least three compounds selected from the group consisting of the compounds (10), (12), (13), (36), (45), (56) are used , (82) and (83) shown in claim 1. 6. El uso según la reivindicación 1, en el que se usan los compuestos (12), (13) y (82) mostrados en la reivindicación 1.6. The use according to claim 1, wherein the compounds (12), (13) and (82) shown in claim 1 are used. 7. El uso según una cualquiera de las reivindicaciones anteriores, que usa adicionalmente el compuesto (3)7. The use according to any one of the preceding claims, which additionally uses the compound (3) 55 1010 15fifteen 20twenty 2525 3030 3535 imagen11image11 8. El uso según una cualquiera de las reivindicaciones anteriores, que usa adicionalmente el compuesto (18)8. The use according to any one of the preceding claims, which additionally uses the compound (18) imagen12image12 9. El uso según una cualquiera de las reivindicaciones 1 a 8, en el que la sopa comprende no más de 500 mg de sodio por ración, o9. The use according to any one of claims 1 to 8, wherein the soup comprises no more than 500 mg of sodium per serving, or no más de 250 mg de sodio por ración, o no más de 100 mg de sodio por ración.no more than 250 mg of sodium per serving, or no more than 100 mg of sodium per serving. 10. El uso según una cualquiera de las reivindicaciones 1 a 8, en el que la sopa comprende no más de 0,25 por ciento en peso de sodio, o10. The use according to any one of claims 1 to 8, wherein the soup comprises no more than 0.25 weight percent sodium, or no más de 0,04 por ciento en peso de sodio.no more than 0.04 percent by weight of sodium. 11. El uso de la reivindicación 1, en el que la sopa también contiene una sal (c) que imparte un sabor salado, en el que la sal (c) se selecciona de una sal de sodio, litio, potasio, amonio o alcalinotérreo, siendo seleccionado el anión de la sal de cloruro, fosfato, glutamato, nitrito, nitrato, bicarbonato, lactato, citrato y estearoillactilato.11. The use of claim 1, wherein the soup also contains a salt (c) that imparts a salty taste, wherein the salt (c) is selected from a sodium, lithium, potassium, ammonium or alkaline earth salt , the anion being selected from the chloride, phosphate, glutamate, nitrite, nitrate, bicarbonate, lactate, citrate and stearoillactylate salt. 12. El uso de la reivindicación 11, en el que la sal (c) es cloruro de sodio.12. The use of claim 11, wherein the salt (c) is sodium chloride. 13. El uso según una cualquiera de las reivindicaciones 1 a 12, en el que el compuesto (a) usado se produjo sintéticamente.13. The use according to any one of claims 1 to 12, wherein the compound (a) used was synthetically produced. 14. El uso según una cualquiera de las reivindicaciones 1 a 12, en el que el compuesto (a) usado se extrajo de fuentes naturales seleccionadas de plantas y fuentes microbianas.14. The use according to any one of claims 1 to 12, wherein the compound (a) used was extracted from selected natural sources of plants and microbial sources. 15. El uso de la reivindicación 13 o 14, en el que el compuesto (a) usado se aisló o purificó.15. The use of claim 13 or 14, wherein the compound (a) used was isolated or purified. 16. El uso de una cualquiera de las reivindicaciones 1 a 15, en el que el compuesto (a) está presente en la sopa en una cantidad de 0,01 a 2% en peso.16. The use of any one of claims 1 to 15, wherein the compound (a) is present in the soup in an amount of 0.01 to 2% by weight. 17. El uso según cualquiera de las reivindicaciones precedentes, en el que el compuesto (a) se selecciona de los compuestos (10), (12), (29), (36), (37), (48), (56), (66), (83) y (84) mostrados en la reivindicación 1.17. The use according to any of the preceding claims, wherein the compound (a) is selected from the compounds (10), (12), (29), (36), (37), (48), (56 ), (66), (83) and (84) shown in claim 1.
Compuesto  Compound
12 13 83 10 37 36 45 18 56 82 3 84 41 48 53 44 62 43    12 13 83 10 37 36 45 18 56 82 3 84 41 48 53 44 62 43
Concentración  Concentration
12  12
l ppm X X X X X X X X X X X X X X X X X X  l ppm X X X X X X X X X X X X X X X X X X
13  13
10 ppm 3.4 X X X X X X X X X X X X X X X X X  10 ppm 3.4 X X X X X X X X X X X X X X X X X
83  83
1 ppm 3.2; 4.2 3.7; 4.5 X X X X X X X X X X X X X X X X  1 ppm 3.2; 4.2 3.7; 4.5 X X X X X X X X X X X X X X X X
10  10
1 ppm 3.9 3.1 3.9 X X X X X. X X X X X X X X X X  1 ppm 3.9 3.1 3.9 X X X X X. X X X X X X X X X X
37  37
10 ppm 3.0; 4.4 3.5 4.1 4.1 X X X X X X X X X X X X X X  10 ppm 3.0; 4.4 3.5 4.1 4.1 X X X X X X X X X X X X X X
36  36
0.1 ppm 3.9 3.8 3.5 3.3; 3.4 3.1 X X X X X X X X X X X X X  0.1 ppm 3.9 3.8 3.5 3.3; 3.4 3.1 X X X X X X X X X X X X X
45  Four. Five
1 0 ppm 3.6; 3.9 3.4; 4.1 2.4; 3.4 3.4 3.3 4 X X X X X X X X X X X X  1.0 ppm 3.6; 3.9 3.4; 4.1 2.4; 3.4 3.4 3.3 4 X X X X X X X X X X X X
18  18
10 ppm 2.6; 4.0 3.1 3.2; 3.9 3.3 3.8 3.4 2.7: 3.3 X X X X X X X X X X X  10 ppm 2.6; 4.0 3.1 3.2; 3.9 3.3 3.8 3.4 2.7: 3.3 X X X X X X X X X X X
56  56
1 0 ppm 2.6 3.4 3.8 4.1 3.4; 4.4 3.1; 3.7 3.1 3.4 X X X X X X X X X X  1 0 ppm 2.6 3.4 3.8 4.1 3.4; 4.4 3.1; 3.7 3.1 3.4 X X X X X X X X X X
82  82
1 ppm 3.2 3.4 X X X X X X X X X  1 ppm 3.2 3.4 X X X X X X X X X
3  3
0.1 ppm 3.5 X X X X X X X X  0.1 ppm 3.5 X X X X X X X X
84  84
1 ppm 3.8 3.2 3.5 3.4 X X X X X X X  1 ppm 3.8 3.2 3.5 3.4 X X X X X X X
41  41
1 0 ppm '■> '•v J .3 3 3.1 X X X X X X  1 0 ppm '■>' • v J .3 3 3.1 X X X X X X
48  48
10 ppm 3.4 3.3 3.3 X X X X X  10 ppm 3.4 3.3 3.3 X X X X X
53  53
1 ppm 3.0 2.9 3.0 X X X X  1 ppm 3.0 2.9 3.0 X X X X
44  44
10 ppm 3.2 3.3 3.1 3 2.8 X X X  10 ppm 3.2 3.3 3.1 3 2.8 X X X
62  62
10 ppm 3.0 3.1 3.0 2.9 2.9 X X  10 ppm 3.0 3.1 3.0 2.9 2.9 X X
43  43
10 ppm 3.1 3.2 3.1 3.1 3.1 X  10 ppm 3.1 3.2 3.1 3.1 3.1 X
FIG. 1FIG. one
Compuesto (Concentración)  Compound (Concentration)
12 13 83 10 37 36 45 18 56 82 3 84 41 48 53 44 62 43  12 13 83 10 37 36 45 18 56 82 3 84 41 48 53 44 62 43
12 (1 ppm)  12 (1 ppm)
X X X X X X X X X X X X X X X X X X  X X X X X X X X X X X X X X X X X X
13 (10 ppm)  13 (10 ppm)
7,9 X X X X X X X X X X X X X X X X X  7.9 X X X X X X X X X X X X X X X X X
83 (1 ppm)  83 (1 ppm)
8,0 7,9 X X X X X X X X X X X X X X X X  8.0 7.9 X X X X X X X X X X X X X X X X
1.0 (1 ppm)  1.0 (1 ppm)
7,7 7,9 7,9 X X X X X X X X X X X X X X X  7.7 7.9 7.9 X X X X X X X X X X X X X X X
37 (10 ppm)  37 (10 ppm)
8,1 X X X X X X X X X X X X X X  8.1 X X X X X X X X X X X X X X
36 (0,1 ppm)  36 (0.1 ppm)
8,! 7,8 7,8 X X X X X X X X X X X X X  8! 7.8 7.8 X X X X X X X X X X X X X
45 (10 ppm)  45 (10 ppm)
8,2 8,1 X X X X X X X. X X X X X  8.2 8.1 X X X X X X X. X X X X X
18 (10 ppm)  18 (10 ppm)
8,3- 9,0 8,0 8,1 8,0 7,9 X X X X X X X X X X X  8.3- 9.0 8.0 8.1 8.0 7.9 X X X X X X X X X X X
56 (10 ppm)  56 (10 ppm)
8,1 7,9 8,0 8,0 8,2 X X X X X X X X X X  8.1 7.9 8.0 8.0 8.2 X X X X X X X X X X
82 (1 ppm)  82 (1 ppm)
8,3 7,6 7,6 8,2 8,3 7,9 X X X X X X X X X  8.3 7.6 7.6 8.2 8.3 7.9 X X X X X X X X X
3 (0,1 ppm)  3 (0.1 ppm)
8,2 7,7 7,9 7,9 8,5 8,4 8,3 7,9 8,3 X X X X X X X X  8.2 7.7 7.9 7.9 8.5 8.4 8.3 7.9 8.3 X X X X X X X X
84 (1 ppm)  84 (1 ppm)
8,2 8,8 8,0 7,7 8,1 7,8 7,9 X X X X X X X  8.2 8.8 8.0 7.7 8.1 7.8 7.9 X X X X X X X
41 (10 ppm)  41 (10 ppm)
7,7 7,S 7,6 X X X X X X X  7.7 7, S 7.6 X X X X X X X
48 (10 ppm)  48 (10 ppm)
7,8 X X X X X X  7.8 X X X X X X
53 (1 ppm)  53 (1 ppm)
8,0 8,1 7,9 7,6 8,1 8,0 7,9 8,0 X X X X X  8.0 8.1 7.9 7.6 8.1 8.0 7.9 8.0 X X X X X
44 (10 ppm)  44 (10 ppm)
7,4 7,7 7,8 8,1 7,9 7,9 8,0 7,8 X X X X  7.4 7.7 7.8 8.1 7.9 7.9 8.0 7.8 X X X X
62 (10 ppm)  62 (10 ppm)
7,7 7,5 X X X  7.7 7.5 X X X
43 (10 ppm)  43 (10 ppm)
7,8 8,0 7,8 7,9 8,0 8,0 7,9 7,8 8,1 X X  7.8 8.0 7.8 7.9 8.0 8.0 7.9 7.8 8.1 X X
FIG. 2FIG. 2
ES14705945.5T 2013-02-08 2014-02-07 Sodium Reduced Food Products Active ES2675018T3 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201361762798P 2013-02-08 2013-02-08
US201361762792P 2013-02-08 2013-02-08
US201361762781P 2013-02-08 2013-02-08
US201361762804P 2013-02-08 2013-02-08
US201361762798P 2013-02-08
US201361762792P 2013-02-08
US201361762804P 2013-02-08
US201361762781P 2013-02-08
US201361763274P 2013-02-11 2013-02-11
US201361763244P 2013-02-11 2013-02-11
US201361763300P 2013-02-11 2013-02-11
US201361763244P 2013-02-11
US201361763274P 2013-02-11
US201361763300P 2013-02-11
PCT/US2014/015244 WO2014124222A1 (en) 2013-02-08 2014-02-07 Reduced sodium food products

Publications (1)

Publication Number Publication Date
ES2675018T3 true ES2675018T3 (en) 2018-07-05

Family

ID=50138012

Family Applications (7)

Application Number Title Priority Date Filing Date
ES18201716T Active ES2925071T3 (en) 2013-02-08 2014-02-07 Reduced sodium food products
ES18164825T Active ES2831028T3 (en) 2013-02-08 2014-02-07 Reduced sodium food products
ES20175617T Active ES2936634T3 (en) 2013-02-08 2014-02-07 Reduced Sodium Food Products
ES14705944.8T Active ES2671954T3 (en) 2013-02-08 2014-02-07 Sodium Reduced Food Products
ES14705945.5T Active ES2675018T3 (en) 2013-02-08 2014-02-07 Sodium Reduced Food Products
ES14705458T Active ES2704880T3 (en) 2013-02-08 2014-02-07 Food products reduced in sodium
ES14705459.7T Active ES2675215T3 (en) 2013-02-08 2014-02-07 Sodium Reduced Food Products

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES18201716T Active ES2925071T3 (en) 2013-02-08 2014-02-07 Reduced sodium food products
ES18164825T Active ES2831028T3 (en) 2013-02-08 2014-02-07 Reduced sodium food products
ES20175617T Active ES2936634T3 (en) 2013-02-08 2014-02-07 Reduced Sodium Food Products
ES14705944.8T Active ES2671954T3 (en) 2013-02-08 2014-02-07 Sodium Reduced Food Products

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES14705458T Active ES2704880T3 (en) 2013-02-08 2014-02-07 Food products reduced in sodium
ES14705459.7T Active ES2675215T3 (en) 2013-02-08 2014-02-07 Sodium Reduced Food Products

Country Status (11)

Country Link
US (4) US11540539B2 (en)
EP (7) EP3732994B1 (en)
JP (6) JP2016509830A (en)
CN (4) CN105189460B (en)
BR (2) BR112015018847A2 (en)
CA (3) CA2900710C (en)
DK (7) DK3366677T3 (en)
ES (7) ES2925071T3 (en)
FI (1) FI3732994T3 (en)
PT (7) PT2954037T (en)
WO (13) WO2014124222A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014124222A1 (en) 2013-02-08 2014-08-14 General Mills, Inc. Reduced sodium food products
CN105384721A (en) * 2015-12-07 2016-03-09 西宁意格知识产权咨询服务有限公司 Novel biphenyl cyclooctene lignin compound, and preparation method and application thereof
US11078157B1 (en) 2018-01-31 2021-08-03 University Of Oregon Compound embodiments that release H2S by reaction with a reactive compound and methods of making and using the same
US11040942B1 (en) 2018-01-31 2021-06-22 University Of Oregon Compound embodiments for hydrogen sulfide production and methods of making and using the same
US11700869B2 (en) * 2018-06-27 2023-07-18 Pepsico, Inc. Mouthfeel enhancing composition
EP3756474B1 (en) 2019-06-25 2024-03-06 Analyticon Discovery GmbH An extract of persea
US20220273011A1 (en) * 2019-11-11 2022-09-01 Firmenich Sa Gingerol compounds and their use as flavor modifiers
EP4048086A1 (en) * 2020-03-05 2022-08-31 Firmenich SA 11-oxo-cucurbitanes and their use as flavor modifiers
US20220218007A1 (en) * 2021-01-14 2022-07-14 Raghavi Kantharuban Methods and composition to reduce salt in food products
US20220248732A1 (en) * 2021-02-05 2022-08-11 Frito-Lay North America, Inc. Saltiness-Perception Enhancing Compounds
EP4277474A1 (en) * 2021-04-06 2023-11-22 Firmenich SA Use of gingerdiol compounds to enhance flavor
CN113582981B (en) * 2021-07-08 2023-09-05 中国科学院昆明植物研究所 Novel diaryl heptane-flavanone hybrid, and pharmaceutical composition and application thereof

Family Cites Families (291)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160862A (en) 1972-06-12 1979-07-10 Sterling Drug Inc. 1-Acyl-3-(amino-lower-alkyl)indoles
JPS5810429A (en) 1981-07-07 1983-01-21 Inoue Japax Res Inc Wire cut discharge processing method
JPS58212764A (en) * 1982-06-03 1983-12-10 Sadao Nakayama Seasoning compositions and food using them
HU194220B (en) 1985-04-19 1988-01-28 Richter Gedeon Vegyeszet Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof
US4997672A (en) * 1987-03-10 1991-03-05 Virginia Commonwealth University Salt taste enhancer
DE3924607A1 (en) 1989-07-21 1991-01-24 Singer Peter Dr Sc Med Diet food contg. omega-3-fatty acid, omega-6-fatty acid - with sodium ions and potassium ions, reducing risk of heart and circulation disease
JPH03161470A (en) 1989-11-17 1991-07-11 Nisshin Flour Milling Co Ltd Indole derivative
US5232684A (en) 1990-06-29 1993-08-03 The United States Of America As Represented By The Department Of Health And Human Services Labelled resiniferatoxin, compositions thereof, and methods for using the same
US5874479A (en) 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
DE4217842A1 (en) 1992-05-29 1993-12-02 Dietl Hans Pharmaceutical compsns. for intravenous or intra-coronary admin. - are aq. emulsions contg. 1,4-di:hydro:pyridine calcium antagonist, natural oil and phosphatidyl-choline or phosphatidyl-ethanolamine
US5260091A (en) * 1992-10-21 1993-11-09 Interneuron Pharmaceuticals Inc. Salt taste enhancers
US5620989A (en) 1992-10-28 1997-04-15 Merck Sharp & Dohme Limited 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits
DK0680470T3 (en) 1993-01-21 1997-04-28 Merrell Pharma Inc
US5719148A (en) 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
JP3014575B2 (en) 1993-10-29 2000-02-28 寳酒造株式会社 Taste improver
US5494919A (en) 1993-11-09 1996-02-27 Merck & Co., Inc. 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
JP3575705B2 (en) 1994-08-02 2004-10-13 小川香料株式会社 Method for producing gingerol and shogaol
EP0804434A1 (en) 1994-08-02 1997-11-05 MERCK SHARP & DOHME LTD. Azetidine, pyrrolidine and piperidine derivatives
US5919614A (en) 1994-10-19 1999-07-06 Lifecell Corporation Composition comprising three platelet lesion inhibitors for platelet storage
US6221669B1 (en) 1994-10-19 2001-04-24 Lifecell Corporation Prolonged preservation of blood platelets
CA2207201A1 (en) 1994-12-06 1996-06-13 Caroline Henry Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists
US5700806A (en) 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
TW453881B (en) 1995-10-16 2001-09-11 Kao Corp Cosmetic composition comprising amide derivatives
NZ321575A (en) 1995-10-30 1999-05-28 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives
GB9523243D0 (en) 1995-11-14 1996-01-17 Merck Sharp & Dohme Therapeutic agents
TW429256B (en) 1995-12-27 2001-04-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
JP3549366B2 (en) 1996-06-20 2004-08-04 株式会社林原生物化学研究所 Method for enhancing taste and / or umami from salt in food and drink
DE69834038D1 (en) 1997-07-01 2006-05-18 Isis Pharmaceutical Inc COMPOSITIONS AND METHOD FOR THE ADMINISTRATION OF OLIGONUCLEOTIDES OVER THE DISHES
GB9807607D0 (en) 1998-04-08 1998-06-10 Bp Chem Int Ltd Fuel additive
US6303620B1 (en) 1998-05-11 2001-10-16 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6841539B1 (en) 1998-05-21 2005-01-11 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
AU745880B2 (en) 1998-05-21 2002-04-11 Isis Pharmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
US5948460A (en) 1998-07-27 1999-09-07 Takasago International Corporation Flavored product additive and method for using same
JP4267783B2 (en) 1998-10-02 2009-05-27 株式会社インテリジェントセンサーテクノロジー Taste recognition device
AU3515700A (en) 1999-03-10 2000-09-28 Axys Pharmaceuticals, Inc. Process for the synthesis of dihydropyridones
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
RU2164766C1 (en) * 1999-10-22 2001-04-10 Емец Юрий Алексеевич Food biologically active addition
DE60102402T2 (en) 2000-02-10 2005-03-10 Loders Croklaan B.V. Fat blends with crystal modifiers
GB0003397D0 (en) 2000-02-14 2000-04-05 Merck Sharp & Dohme Therapeutic agents
JP3394737B2 (en) 2000-03-03 2003-04-07 正田醤油株式会社 Low salt soy sauce seasoning
DE20008343U1 (en) 2000-05-09 2000-09-14 Abatu Fuat Spice mix
DE60114708T2 (en) 2000-06-05 2006-07-20 Loders Croklaan B.V. Ursolic acid and oleanolic acid containing mixtures
GB0023918D0 (en) * 2000-09-29 2000-11-15 King S College London Antiparasitic compounds
JP2002125616A (en) 2000-10-27 2002-05-08 Apio Club:Kk Method for producing herb salt
US20120237626A9 (en) 2000-12-05 2012-09-20 Palu Afa Kehaati Profiles of lipid proteins and inhibiting HMG-CoA reductase
JP4277294B2 (en) 2000-12-26 2009-06-10 佐藤食品工業株式会社 Method for improving the flavor of food
WO2002080904A1 (en) * 2001-04-05 2002-10-17 Kyowa Hakko Kogyo Co., Ltd. Liver funcion protecting or ameliorating agent
AU772384B2 (en) * 2001-05-09 2004-04-29 Nestec S.A. Vitex agnus castus extract
JP2002345430A (en) 2001-05-28 2002-12-03 Kyowa Hakko Kogyo Co Ltd Method for enhancing salt taste, salt taste enhancer, salt taste seasoning, and salt taste-enhanced food and beverage
JP2002370922A (en) 2001-06-15 2002-12-24 Azuma Noen:Kk Cosmetic containing japanese plum extract
WO2003008632A1 (en) 2001-07-16 2003-01-30 Hoegestaett Edward Fatty acid conjugation as a method for screening of potentially bioactive substances
WO2003018549A2 (en) 2001-08-30 2003-03-06 Chemocentryx, Inc. Bicyclic compounds as inhibitors of chemokine binding to us28
JP4278896B2 (en) 2001-11-02 2009-06-17 丸善製薬株式会社 Hihatsu fruit extract composition, food and drink containing Hihatsu fruit extract, and method for improving taste of Hihatsu fruit extract
CN1347664A (en) 2001-11-07 2002-05-08 林泽垠 Natural non-salt salty food additive and its prepn
US6743461B1 (en) * 2001-11-09 2004-06-01 Ecosalt Corporation Salt substitute compositions
CN1435123A (en) 2002-02-01 2003-08-13 冯旭斌 Rolled chilli
WO2003075929A1 (en) 2002-03-13 2003-09-18 Janssen Pharmaceutica N.V. Inhibitors of histone deacetylase
US6929809B2 (en) 2002-03-26 2005-08-16 Council Of Scientific And Industrial Research Preparation of nutrient rich salt of plant origin
US6691780B2 (en) 2002-04-18 2004-02-17 Halliburton Energy Services, Inc. Tracking of particulate flowback in subterranean wells
WO2003092676A1 (en) 2002-04-29 2003-11-13 The General Hospital Corporation Compositions and methods for preventing abuse of orally administered medications
MY141736A (en) 2002-10-08 2010-06-15 Elanco Animal Health Ireland Substituted 1,4-di-piperidin-4-yi-piperazine derivatives and their use as neurokinin antagonists
US20100173993A1 (en) 2003-02-06 2010-07-08 Sawyer Anthony J Controlled release biocidal salts
GB0306399D0 (en) 2003-03-20 2003-04-23 Ineos Fluor Holdings Ltd Process for reducing the concentration of undesired compounds in a composition
US20040202735A1 (en) 2003-04-08 2004-10-14 Moore Bob M. Method and kit for controlling bleeding
ES2307025T3 (en) 2003-06-10 2008-11-16 Janssen Pharmaceutica Nv COMBINATION OF OPIOIDES AND A DERIVATIVE OF PIPERAZINE FOR THE TREATMENT OF PAIN.
US20060128721A1 (en) 2003-06-10 2006-06-15 Janssens Frans E Novel formulations of opioid-based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
US20080060576A1 (en) 2003-06-27 2008-03-13 Sumitomo Electric Industries, Ltd. Wafer Holder for Semiconductor Manufacturing Device and Semiconductor Manufacturing Device in Which It Is Installed
JP2005013138A (en) 2003-06-27 2005-01-20 Kiyomitsu Kawasaki Method for producing spice flavor
JP2005015684A (en) 2003-06-27 2005-01-20 Kiyomitsu Kawasaki Method for preparing vegetable flavor
US20050031717A1 (en) 2003-07-09 2005-02-10 Desimone John A. Salt taste modification
RU2363259C2 (en) 2003-07-10 2009-08-10 Такасаго Интернешнл Корпорейшн Taste intensifying agent, food products ot beverages containing taste intensifying agent and taste intensifying method
US20050025844A1 (en) 2003-08-02 2005-02-03 Matthias Boldt Weight control compositions and methods
US7846422B2 (en) 2003-08-04 2010-12-07 Kao Corporation Method for prevention or treatment of periodontal diseases and composition for an oral cavity
NL1026826C2 (en) 2003-08-13 2007-01-04 Pharmacia Corp Substituted pyridinones.
ES2481167T3 (en) 2003-08-22 2014-07-29 Dupont Nutrition Biosciences Aps Composition comprising a bacteriocin and an extract from a plant of the Labiatae family
GB2388581A (en) 2003-08-22 2003-11-19 Danisco Coated aqueous beads
JP2005075785A (en) 2003-09-01 2005-03-24 Japan Science & Technology Agency Piperidine derivative and method for producing the same
US20070093552A1 (en) 2003-09-22 2007-04-26 Futoshi Matsuyama Early insulin secretion stimulator
US20070059351A1 (en) 2003-10-17 2007-03-15 Murrell George A C Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods
CN100391364C (en) * 2003-10-30 2008-06-04 张湘生 Flavouring spicery
TWI356681B (en) 2003-11-12 2012-01-21 J Oil Mills Inc Body taste improver comprising long-chain highly u
US8389031B2 (en) 2005-05-23 2013-03-05 Kraft Foods Global Brands Llc Coated delivery system for active components as part of an edible composition
JP2007514727A (en) 2003-12-19 2007-06-07 リピッド ニュートリション ベスローテン フェンノートシャップ Use of a composition comprising oleanolic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity
CA2556589A1 (en) 2004-02-24 2005-09-01 Bioaxone Therapeutique Inc. 4-substituted piperidine derivatives
US20050215635A1 (en) * 2004-03-08 2005-09-29 Rafi M Mohamed Diarylheptanoid compounds and uses thereof
WO2005097261A1 (en) 2004-03-30 2005-10-20 Sapphire Therapeutics, Inc. Method of reducing c-reactive protein using growth hormone secretagogues
JP2005298449A (en) 2004-04-15 2005-10-27 Astellas Pharma Inc 4-aminopyrimidine derivative
EP1763349A2 (en) 2004-06-03 2007-03-21 Jonathan J. Burbaum Pharmaceutical compositions for the treatment of pruritus
KR20050122373A (en) 2004-06-24 2005-12-29 대한민국(서울대학교 총장) Composition comprising a root extract of salvia miltiorrhiza or dimethyl lithospermate b as a sodium channel agonist
JP4993407B2 (en) 2004-08-04 2012-08-08 大正製薬株式会社 Triazole derivative
DE102004038396A1 (en) 2004-08-06 2006-03-30 Lothar Sellin Device (I), for coating medicinal products, comprises equipment for producing ultrasound and a vacuum chamber containing retaining means for one or more medicinal products
PL1786272T3 (en) 2004-08-11 2015-02-27 Intercontinental Great Brands Llc Warming compositions and delivery systems therefor
ES2388501T3 (en) 2004-08-12 2012-10-16 Helsinn Healthcare S.A. Use of growth hormone secretagogues to stimulate the motility of the gastrointestinal system
EP1789090A2 (en) 2004-09-02 2007-05-30 Bionaut Pharmaceuticals, Inc. Combinatorial chemotherapy treatment using na+/k+-atpase inhibitors
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
CA2582324A1 (en) 2004-10-01 2006-04-13 Merck & Co., Inc. Compositions and methods for treating ophthalmic diseases
WO2006044916A2 (en) 2004-10-18 2006-04-27 Bionaut Pharmaceuticals, Inc. Use of na+/ k+-atpase inhibitors and antagonists thereof
JP2006124322A (en) 2004-10-28 2006-05-18 Takasago Internatl Corp Hyaluronidase inhibitor, skin care composition for external use containing the hyaluronidase inhibitor, and oral composition containing the same
US20080103202A1 (en) 2004-11-08 2008-05-01 Chris Ferguson Method of preparing creatine ester salts and uses thereof.
CA2589260A1 (en) * 2004-11-29 2006-06-01 Aloecorp, Inc. Dehydration of food combinations
US20080268092A1 (en) 2004-12-01 2008-10-30 Dacanay Rhodel G Capsaicin Nutritional Supplement
JP4942141B2 (en) 2004-12-02 2012-05-30 江崎グリコ株式会社 Glucose transfer method to carboxyl group
JP2008524267A (en) 2004-12-22 2008-07-10 メステックス アクチェンゲゼルシャフト Mixtures of vanilloid receptor agonists and nerve regeneration substance inhibitors, their use to produce analgesics, and methods of applying the analgesics
ATE549018T1 (en) 2004-12-28 2012-03-15 Mestex Ag USE OF A VANILLOID RECEPTOR AGONIST TOGETHER WITH A GLYCOSAMINOGLYCAN OR PROTEOGLYCAN FOR THE PRODUCTION OF AN AGENT FOR THE TREATMENT OF JOINT PAIN AND METHOD OF APPLYING SUCH AGENT
NZ556261A (en) 2005-01-28 2012-04-27 Adm Alliance Nutrition Inc Animal feed compositions capable of reducing the incidence of fescue toxicosis in mammas containing a coated or encapsulated capsaicin product and an adsorbant
DE602005002728T2 (en) 2005-02-18 2008-07-24 The Procter & Gamble Company, Cincinnati Caffeine-containing confectionery
US20060198806A1 (en) 2005-03-04 2006-09-07 Reilly Christopher A Capsaicinoid decontamination compositions and methods of use
JP2006238814A (en) 2005-03-04 2006-09-14 Ogawa & Co Ltd Flavor enhancing agent, seasoning, food and drink containing the enhancing agent and the seasoning, and flavor enhancing method
EP1859035B1 (en) 2005-03-08 2016-01-13 Agency for Science, Technology and Research Immobilised enzymes
US20060204601A1 (en) 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
JP2006246857A (en) 2005-03-14 2006-09-21 Showa Sangyo Co Ltd Oil and fat composition, and food
WO2006107832A2 (en) 2005-04-05 2006-10-12 President And Fellows Of Harvard College Methods and kits for isolating nucleic acids
JP4508932B2 (en) 2005-04-25 2010-07-21 小川香料株式会社 Taste enhancer, flavor containing the taste enhancer, and food and drink containing the flavor
MX349340B (en) 2005-05-23 2017-07-24 Intercontinental Great Brands Llc Taste potentiator compositions and beverages containing same.
CN1736485A (en) 2005-06-29 2006-02-22 上海美迪西生物医药有限公司 Use of vanillin receptor agonist in preparation of product for resisting Alzheimer disease
WO2007018514A1 (en) 2005-07-28 2007-02-15 Glaxo Group Limited Novel m3 muscarinic acetylcholine receptor antagonists
WO2007018508A1 (en) 2005-07-28 2007-02-15 Glaxo Group Limited Novel m3 muscarinic acetycholine receptor antagonists
GB0520845D0 (en) 2005-10-14 2005-11-23 Hofmann Thomas F Salt enhancing compounds and use
US9125833B2 (en) 2005-11-02 2015-09-08 Relmada Therapeutics, Inc. Multimodal abuse resistant and extended release opioid formulations
US20070184137A1 (en) 2005-11-29 2007-08-09 Palu Afa K Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes
CN100490870C (en) 2006-01-13 2009-05-27 东莞广发制药有限公司 Spleen and kidney invigorating preparation and its preparing process and inspection method
JP5218737B2 (en) 2006-02-06 2013-06-26 大正製薬株式会社 Sphingosine-1-phosphate binding inhibitor
JP2007232574A (en) 2006-03-01 2007-09-13 Ajinomoto Co Inc Screening method of sympathetic nerve activator
CN1820646A (en) 2006-03-11 2006-08-23 刘仁虎 Health food containing paederia scandens
CN1857586A (en) 2006-03-28 2006-11-08 石圣洪 Osteoporsis treating Chinese medicine preparation and its preparing process
CN1857343A (en) 2006-04-11 2006-11-08 徐蕾 Chinese medicine composition for preventing and treating viral cold and throat disease and its preparing method
CA2544227A1 (en) 2006-04-20 2007-10-20 Metabev Inc. Food product containing policosanols
US20070248621A1 (en) 2006-04-24 2007-10-25 Metabev Llc Food product containing policosanols
US9789161B2 (en) 2006-04-28 2017-10-17 Warsaw Orthopedic, Inc. Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin
US8916611B2 (en) 2006-04-28 2014-12-23 Warsaw Orthopedic, Inc. Pharmaceutical removal of neuronal extensions from a degenerating disc
US20070287991A1 (en) 2006-06-08 2007-12-13 Mckay William F Devices and methods for detection of markers of axial pain with or without radiculopathy
JP2008000005A (en) * 2006-06-20 2008-01-10 Shizuoka Prefecture Agent for ameliorating dysphagia and food for ameliorating dysphagia
JP5265142B2 (en) * 2006-06-21 2013-08-14 株式会社Adeka Salt composition containing salty taste enhancer
CN101095800A (en) 2006-06-29 2008-01-02 朱靖华 Development of paster for treating mouth ulcer
WO2008011083A2 (en) 2006-07-18 2008-01-24 Cornell Research Foundation, Inc. Compounds for enhancing arginase activity and methods of use thereof
WO2008021394A2 (en) 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Pharmaceutical formulations of cannabinoids and method of use
WO2008024490A2 (en) 2006-08-24 2008-02-28 Theraquest Biosciences, Inc. Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use
WO2008027442A2 (en) 2006-08-30 2008-03-06 Theraquest Biosciences, Llc Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
WO2008033351A2 (en) 2006-09-11 2008-03-20 Theraquest Biosciences, Inc. Multimodal abuse resistant and extended release formulations
BRPI0715257B1 (en) 2006-10-04 2023-03-07 Unilever N.V FRACTIONED TOMATO EXTRACT, FLAVOR ENHANCEMENT COMPOSITION, USE OF A FRACTIONED TOMATO EXTRACT, METHOD OF PRODUCTION OF A FRACTIONED TOMATO EXTRACT, METHOD OF PREPARATION OF A PRODUCT AND PRODUCT
CA2606658A1 (en) 2006-10-13 2008-04-13 Mike Tyers Compositions and methods for treating neurological disorders or damage
US20080124753A1 (en) 2006-11-15 2008-05-29 Lee Seunghun Paul SpiceMatrix Technology for Taste Compound Identification
WO2008063603A2 (en) 2006-11-20 2008-05-29 President And Fellows Of Harvard College Methods, compositions, and kits for treating pain and pruritis
US20100068221A1 (en) 2006-12-07 2010-03-18 Arie Gerrit Terdu Low salt food with improved taste
CA2671190A1 (en) 2006-12-07 2008-06-12 Dsm Ip Assets B.V. Low salt food with improved taste
US20090312255A1 (en) 2006-12-14 2009-12-17 The Hospital For Sick Children Stimulation of trpv1+ sensory neurons to control beta-cell stress and islet inflammation in diabetes
CN101562986A (en) * 2006-12-19 2009-10-21 帝斯曼知识产权资产管理有限公司 Reduced-salt dairy product with improved taste
EA200970764A1 (en) 2007-02-13 2010-04-30 ХЕЛСИНН ТЕРАПЬЮТИКС (Ю. Эс.), ИНК. METHOD OF TREATMENT OF DISORDERS CAUSED BY PROLIFERATION OF CELLS WITH THE USE OF STIMULATORS OF THE GROWTH HORMONE SECRETION
WO2008100977A2 (en) 2007-02-14 2008-08-21 N.V. Organon Carbamates therapeutic release agents as amidase inhibitors
US20080199595A1 (en) * 2007-02-15 2008-08-21 Mccormick & Company Salt replacing composition, process for its preparation and food systems containing such composition
BRPI0808150A2 (en) 2007-02-28 2014-07-01 Procter & Gamble METHODS AND TARGETS FOR IDENTIFYING COMPOUNDS FOR REGULATING RHINOVIRUS INFECTION
RU2462048C2 (en) 2007-03-22 2012-09-27 Экосолт Корпорэйшн Non-bitter composition containing no sodium or with low sodium salt content
US20130115320A1 (en) 2007-03-30 2013-05-09 Dynova Laboratories, Inc. Therapeutic agent for intranasal administration and method of making and using same
US20130115321A1 (en) 2007-03-30 2013-05-09 Dynova Laboratories, Inc. Therapeutic agent for intranasal administration and method of making and using same
US20080241117A1 (en) 2007-04-02 2008-10-02 Abdul Gaffar Oral Care Compositions Containing a Mixed Tocopherol Component
US20100080867A1 (en) 2007-04-05 2010-04-01 Givaudan Sa Fermented Ingredient
US8507027B2 (en) 2007-04-09 2013-08-13 Japan Tobacco Inc. Seasoning compositions, salt-like taste enhancer and method for enhancing salt-like taste of food and drink
TWI429436B (en) 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc Methods of treating or preventing emesis using growth hormone secretagogues
US20080268001A1 (en) 2007-04-30 2008-10-30 Lynette Zaidel Oral care composition to reduce or eliminate dental sensitivity
US20080267891A1 (en) 2007-04-30 2008-10-30 Colgate-Palmolive Company Oral Care Composition To Reduce Or Eliminate Dental Sensitivity
WO2008139152A1 (en) 2007-05-11 2008-11-20 Sentinel Oncology Limited N-oxide-containing pharmaceutical compounds
KR100784229B1 (en) 2007-05-17 2007-12-11 주식회사 파이토코 Salicornia herbacea-derived salt and its production process
DE502008002360D1 (en) 2007-06-19 2011-03-03 Symrise Ag Aroma composition for reducing or suppressing undesirable bitter and astringent impression
EP2011495A1 (en) 2007-07-03 2009-01-07 Sygnis Bioscience GmbH & Co. KG Use of piperine and derivatives thereof for the therapy of neurological conditions
KR100891935B1 (en) 2007-07-10 2009-04-08 박양순 The method preparing for a sweet drink made fromfermented rice
KR100903739B1 (en) 2007-08-24 2009-06-19 씨제이제일제당 (주) Granulated seasoning salt and preparation method thereof
JP2010538636A (en) * 2007-09-13 2010-12-16 フイルメニツヒ ソシエテ アノニム Flavor composition for flavor applications
EP2042043A1 (en) 2007-09-26 2009-04-01 Nestec S.A. A shelf-stable taste enhancing cultured savoury base and a process for its preparation
US20100311678A1 (en) 2007-10-04 2010-12-09 Bean Bruce P Methods and compositions for treating cancer and modulating signal transduction and metabolism pathways
CL2007002915A1 (en) 2007-10-10 2008-04-25 Cox Y Compania S A COMPOSITION FOR FOOD, NUTRITIVE SUPPLEMENTS, NUTRACEUTICAL PRODUCTS OR OTHER HUMAN CONSUMPTION THAT INCLUDES SODIUM CHLORIDE, POTASSIUM CHLORIDE, ACIDS AND SWEETENERS, WHERE THE PROPORTIONS OF SUCH COMPONENTS CONFORM TO THE COMPOSITION
EP3320921B1 (en) 2007-11-05 2022-01-05 Ala Wai Pharma, Inc. Formulations for enhanced bioavailability of orally administered polar agents
MX2010005465A (en) 2007-11-19 2010-06-02 Nestec Sa Treatment of oral pharyngeal dysphagia.
WO2009071095A2 (en) 2007-12-05 2009-06-11 Neurokey A/S Prevention of hyperthermia subsequent to hypothermia treatment of ischemia
WO2009071096A2 (en) 2007-12-05 2009-06-11 Neurokey A/S Combination of medical and physical cooling treatment of ischemic effects
WO2009071094A2 (en) 2007-12-05 2009-06-11 Neurokey A/S Combination treatment of ischemic effects
CN101254226B (en) 2007-12-19 2011-01-19 游洪涛 Duliang compound chinese medicine soft capsules
ES2531939T5 (en) 2007-12-21 2019-01-10 Unilever Nv Active fractions of umami and methods to prepare them
CN101214278B (en) 2007-12-26 2012-06-27 沈阳药科大学 New raw material for extracting fructus schizandrae total lignans and preparation technique and use
US9259006B2 (en) 2008-01-30 2016-02-16 Smartwash Solutions, Llc Antimicrobial compositions and methods of use thereof
US20110052763A1 (en) 2008-02-24 2011-03-03 Zohar Nir Use of soluble tomato solids for reducing the salt content of food products
CA2717042A1 (en) 2008-03-11 2009-09-17 The General Hospital Corporation Methods, compositions, and kits for treating pain and pruritis
BR122017026860B1 (en) 2008-03-17 2020-11-10 Givaudan Sa process for forming a salt-enhancing ingredient, flavor composition for food products, food product and method for providing it
JP5596536B2 (en) 2008-03-24 2014-09-24 日本水産株式会社 Salty taste enhancer and food and drink containing the same
WO2009124551A2 (en) 2008-04-09 2009-10-15 Neurokey A/S Use of hypothermia inducing drugs
WO2009124552A2 (en) 2008-04-09 2009-10-15 Neurokey A/S Use of a combination of hypothermia inducing drugs
JP2011518844A (en) 2008-04-25 2011-06-30 ナノバイオ コーポレーション Nanoemulsions for treating fungal, yeast and filamentous fungal infections
EP2306845B1 (en) 2008-06-20 2015-02-18 Givaudan SA Enzymatic process
US20110189161A1 (en) 2008-06-21 2011-08-04 Kenneth Blum Nutrigenomics methods and compositions
JP5452893B2 (en) 2008-06-25 2014-03-26 小川香料株式会社 Taste improving agent for potassium salts or foods and drinks containing potassium salts
US8460657B2 (en) 2008-06-25 2013-06-11 H. Lundbeck A/S Modulation of the TrpV: Vps10p receptor system for the treatment of pain
US8808768B2 (en) 2008-07-21 2014-08-19 Kailash Chandra Agarwal Development of biochemically standardized extracts from fresh rhizomes of turmeric (Curcuma longa) for treatment of diseases caused by hyperuricemia
CN101318985A (en) 2008-07-23 2008-12-10 谢佳良 Preparation method for ursolic acid, produced products and application thereof
US20100034944A1 (en) 2008-08-06 2010-02-11 Martha Lubenova Beyazova Use of Avocado Derivatives in Flavor Applications
WO2010015260A2 (en) 2008-08-07 2010-02-11 Neurokey A/S Administration by infusion for the treatment of ischemic effects
KR100995839B1 (en) 2008-08-08 2010-11-22 주식회사 아이토비 Multi contents display system and method thereof
MX2008010606A (en) 2008-08-18 2010-02-17 Integradora Bravo S A De C V Phytosanitary compositions enhanced with raw vegetable oils and derivatives thereof, and the use thereof for the plague control.
US8143259B2 (en) 2008-08-19 2012-03-27 Janssen Pharmaceutica, Nv Cold menthol receptor antagonists
WO2010026596A2 (en) * 2008-09-08 2010-03-11 Shai Meretzki Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses
AU2008221548A1 (en) 2008-09-19 2010-04-08 Greentaste Pty Ltd Method For and Composition of Excipient Suitable for Use in Herbal Formulations and Formulations Derived Therefrom
WO2010036878A1 (en) 2008-09-26 2010-04-01 The Trustees Of Columbia University In The City Of New York Use of trpv1 receptor agonists in cervical pain and labor
US20100099766A1 (en) 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
US20110237674A1 (en) 2008-10-16 2011-09-29 Novartis Ag Topical nsaid compositions having sensate component
JP2010094081A (en) 2008-10-17 2010-04-30 Kao Corp Food and drink composition
JP5376629B2 (en) 2008-10-24 2013-12-25 長谷川香料株式会社 Flavor degradation inhibitor
JP5159568B2 (en) 2008-11-07 2013-03-06 小林製薬株式会社 Food / beverage composition containing hihatsu extract and method for improving taste of food / beverage composition containing hihatsu extract
US8709391B2 (en) 2008-11-26 2014-04-29 Board Of Regents Of The University Of Texas System Family of pain producing substances and methods to produce novel analgesic drugs
WO2010078392A2 (en) 2008-12-31 2010-07-08 Novozymes North America, Inc. Processes of producing fermentation products
WO2010092467A1 (en) 2009-02-13 2010-08-19 Carlo Ghisalberti Medicament comprising terpenoid cholinesterase inhibitor for treatment of dismotility disorder
CN102340999B (en) * 2009-03-16 2013-10-30 麒麟协和食品株式会社 Agent for enhancing taste of common salt
WO2010108542A1 (en) 2009-03-25 2010-09-30 Nestec S.A. A natural taste enhancing savoury base and a process for its preparation
KR20100109207A (en) 2009-03-31 2010-10-08 충남대학교산학협력단 A method for feeding animal using by the dried powder of epimedium koreanum nakai or the extract thereof showing anti-oxidative activity
KR100987236B1 (en) 2009-03-31 2010-10-12 충남대학교산학협력단 Composition comprising the dried powder of epimedium koreanum nakai or the extract thereof showing anti-oxidative activity
KR101676375B1 (en) 2009-04-09 2016-11-15 시므라이즈 아게 Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent
CN101862312A (en) 2009-04-14 2010-10-20 中国中医科学院中药研究所 New application of 6-gingerol
US8962057B2 (en) 2009-04-29 2015-02-24 The Procter & Gamble Company Methods for improving taste and oral care compositions with improved taste
CN105285906A (en) * 2009-04-29 2016-02-03 阿克佐诺贝尔化学国际公司 Process to prepare a low-sodium salt product, product obtainable thereby and the use thereof
CA2761156C (en) 2009-05-07 2017-03-14 University Of Cincinnati Methods of preventing ischemic injury using peripheral nociceptive stimulation
EP2253226B1 (en) 2009-05-15 2015-07-15 Leibniz-Institut für Pflanzenbiochemie (IPB) Use of hydroxyflavone derivatives for modifying taste
JP5593641B2 (en) * 2009-06-26 2014-09-24 味の素株式会社 Low salt food and beverage composition
KR101140156B1 (en) 2009-07-02 2012-05-02 (주)죽력원 Method for manufacturing functional salt using mulberry leaves
JP2011030562A (en) 2009-07-07 2011-02-17 Seinan Jidosha Kogyo Kk Method for inducing masculinization of gonad of fishes by stress-induced stimulation
CA2767646C (en) 2009-07-10 2019-01-29 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
DE102009027744A1 (en) 2009-07-15 2011-01-20 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Precursor compounds of sweet receptor antagonists for the prevention or treatment of diseases
KR101181216B1 (en) 2009-07-29 2012-09-07 한국생명공학연구원 Pharmaceutical composition comprising extract or fraction from Evodia fructus or quinolone alkaloid compounds
JP4845067B2 (en) 2009-09-01 2011-12-28 国立大学法人奈良女子大学 Salty taste enhancer and salty taste enhancing method
CN102021106B (en) 2009-09-18 2012-11-21 劲牌有限公司 Traditional Chinese medicine health wine and production technology thereof
US20120201945A1 (en) 2009-10-02 2012-08-09 House Foods Corporation Food composition with reinforced or enhanced salty taste and composition containing potassium chloride with suppressed offensive taste
CN101696377B (en) 2009-11-04 2012-10-31 天津市亚天商贸有限公司 Method for preparing hawthorn dry red wine
EP2509444A2 (en) 2009-11-26 2012-10-17 D.Xign Appetite regulating dietary supplement
JP5639758B2 (en) 2009-12-22 2014-12-10 小川香料株式会社 Taste improving agent for potassium salts or foods and drinks containing potassium salts
AU2011212938B2 (en) * 2010-02-04 2015-07-30 Monell Chemical Senses Center Compounds and methods for enhancing salty taste
CA2792878C (en) 2010-03-12 2019-10-22 Government Of The Usa, As Represented By The Sec., Dept. Of Health And Human Services Agonist/antagonist compositions and methods of use
EP2547322A2 (en) 2010-03-15 2013-01-23 Ulrich Dietz Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
BR112012024159A2 (en) 2010-03-23 2019-09-24 Walters Jeffrey texture and taste enhancer and use in food preparation.
JP5869229B2 (en) 2010-04-08 2016-02-24 高砂香料工業株式会社 Salt enhancer and kelp extract containing the same
CN102210441A (en) 2010-04-12 2011-10-12 王晓鹏 Technology for making edible fresh salty taste flavoring agent
US8053007B2 (en) * 2010-04-13 2011-11-08 Mark Innocenzi Compositions and methods for fortifying a base food to contain the complete nutritional value of a standard equivalent unit of the nutritional value of one serving of fruits and vegetables (“SFV”) for human consumption
RU2596989C2 (en) * 2010-04-15 2016-09-10 Крафт Фудс Груп Брэндс Ллс Compounds, compositions and methods for reducing or eliminating bitter taste
JP5733737B2 (en) 2010-06-11 2015-06-10 長谷川香料株式会社 Salty taste enhancer composition
KR100987630B1 (en) 2010-07-01 2010-10-13 주식회사 아이씨푸드 Substitute product of table salt
KR101224873B1 (en) 2010-07-12 2013-01-22 한국식품연구원 Making method of fermented ginger
WO2012015882A1 (en) 2010-07-27 2012-02-02 Bean Bruce P Methods and compositions for preventing and relieving muscle cramps and for recovery from neuromuscular irritability and fatigue following exercise
JP2012025719A (en) 2010-07-28 2012-02-09 Morinaga Milk Ind Co Ltd Proton pump inhibiting agent
US20120034368A1 (en) 2010-08-06 2012-02-09 Matsutani Chemical Industry Co., Ltd. Method for improving salty taste of food or beverage and salty taste improving agent
WO2012035032A2 (en) 2010-09-13 2012-03-22 Givaudan Sa Taste enhancement
CN102396758A (en) 2010-09-13 2012-04-04 李全能 Beverage having multiple health-care functions
CN101949904A (en) 2010-09-22 2011-01-19 中国烟草总公司郑州烟草研究院 Method for determining content of imperatorin in perfume material angelica officinalis tincture for cigarettes
US20140088056A1 (en) 2010-09-28 2014-03-27 President And Fellows Of Harvard College Cardiac glycosides are potent inhibitors of interferon-beta gene expression
CN101999627A (en) 2010-09-29 2011-04-06 重庆合川盐化工业有限公司 Hot pot seasoning salt
WO2012060845A1 (en) 2010-11-05 2012-05-10 University Of Cincinnati Methods of preventing ischemic injury using peripheral nociceptive stimulation
CN102058082B (en) 2010-11-22 2012-10-03 晨光生物科技集团股份有限公司 Efficient extraction and separation technology for effective ingredients of peppers
CN101974399A (en) 2010-11-24 2011-02-16 曹光荣 Functional white wine and preparation method thereof
KR101253041B1 (en) 2010-12-03 2013-04-10 송인상 Manufacturing method of processed salt using medicinal plant
WO2012098281A2 (en) 2011-01-19 2012-07-26 Universidad Miguel Hernández De Elche Trp-receptor-modulating peptides and uses thereof
KR101324926B1 (en) 2011-01-28 2013-11-01 계명대학교 산학협력단 Manufacturing Mathod of Ginger Extract And Ginger Extract Using The Same
KR20120090359A (en) 2011-02-07 2012-08-17 한국식품연구원 Method for extraction of zingiberene in ginger
EP3363437B8 (en) 2011-02-18 2021-11-03 Endo Pharmaceuticals Inc. Aminoindane compounds and use thereof in treating pain
EP2684468A4 (en) * 2011-03-07 2014-08-27 Ajinomoto Kk Salty taste enhancer
US8840938B2 (en) 2011-04-13 2014-09-23 W. Matthew Warnock Bioavailability enhancing composition
JP5872187B2 (en) * 2011-05-17 2016-03-01 小川香料株式会社 Salt enhancer
KR20130003452A (en) 2011-06-30 2013-01-09 목포대학교산학협력단 A method of lite salt
WO2013009827A1 (en) 2011-07-13 2013-01-17 Tempero Pharmaceuticals, Inc. Methods of treatment
JP2013018764A (en) 2011-07-14 2013-01-31 Kao Corp Epithelial sodium channel activator
CN102326768B (en) 2011-07-29 2013-07-31 天津春发生物科技集团有限公司 Savory flavoring
DK2749179T3 (en) 2011-08-26 2019-07-15 Kohjin Life Sciences Co Ltd Yeast extract with flavor enhancing effect
EA029151B1 (en) 2011-09-06 2018-02-28 Курна, Инк. TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF VOLTAGE-GATED SODIUM CHANNELS (SCNxA) WITH SMALL MOLECULES
EP2578210A1 (en) 2011-10-05 2013-04-10 ATB Innovation Ltd. Rottlerin for the treatment of pulmonary hypertension and related diseases and disorders
WO2013052844A1 (en) 2011-10-07 2013-04-11 Pulmatrix, Inc. Methods for treating and diagnosing respiratory tract infections
KR20140076629A (en) 2011-10-20 2014-06-20 크로모셀 코포레이션 Compounds, compositions, and methods for reducing or eliminating bitter taste
EP2771320B1 (en) 2011-10-24 2016-06-22 Endo Pharmaceuticals Inc. Cyclohexylamines
GB201118481D0 (en) 2011-10-26 2011-12-07 Givaudan Sa Organic compounds
GB2496898B (en) 2011-11-25 2020-10-28 Petroliam Nasional Berhad Petronas Corrosion inhibition
KR20130076905A (en) 2011-11-28 2013-07-09 김광순 Dry seaweed flavoring natural seasonings for food. Anchovy salt manufacturing method
WO2013085014A1 (en) 2011-12-06 2013-06-13 日本水産株式会社 Taste-improving agent and food or drink containing same
CN102423352B (en) 2011-12-13 2013-10-09 广东众生药业股份有限公司 Preparation method of Chinese medicinal granules for treating cardio-cerebrovascular diseases
JP5906541B2 (en) 2011-12-22 2016-04-20 国立大学法人高知大学 Gingerol-containing composition
UA112671C2 (en) 2011-12-23 2016-10-10 Нестек С.А. METHOD OF OBTAINING TASTE AND AROMATIC COMPOSITION WITH TASTE AND Aroma OF MIND
KR101268782B1 (en) 2011-12-29 2013-05-29 세종대학교산학협력단 Preparation method of salt trapped in mushroon mycelium cell wall and noodle containing the same
WO2013103031A1 (en) 2012-01-06 2013-07-11 株式会社カネカ Salty taste enhancer
JP3179252U (en) 2012-07-13 2012-10-25 株式会社美多加堂 Powdered salt for processed foods
CN102763829A (en) * 2012-07-24 2012-11-07 朱建辉 Production process of spicy distillers' grains mixture
CN102987068A (en) 2012-10-10 2013-03-27 合肥永生禽业有限责任公司 Pig feed capable strengthening appetite and preparation method of pig feed
CN102987123A (en) 2012-10-10 2013-03-27 合肥永生禽业有限责任公司 Silkworm excrement pig feed and preparation method thereof
CN102987128A (en) 2012-10-10 2013-03-27 合肥永生禽业有限责任公司 Pagoda tree flower pig feed additive
CN102934746B (en) 2012-10-13 2013-09-25 安徽泗县成安牧业科技有限公司 Fermentation plant leaf breeding pig feed
CN102907615A (en) 2012-10-25 2013-02-06 沈阳田东科研有限公司 Making method of braised chicken soup noodles
CN102948645B (en) 2012-10-29 2013-11-06 合肥市益农养殖有限公司 Mulberry duck feed and preparation method thereof
CN102972558A (en) 2012-12-05 2013-03-20 袁辉 Process for manufacturing heat-clearing and hypertension-reducing tea
CN102972552A (en) 2012-12-05 2013-03-20 袁辉 Heat-clearing and hypertension-reducing tea
WO2014124222A1 (en) * 2013-02-08 2014-08-14 General Mills, Inc. Reduced sodium food products
CN103141575A (en) 2013-03-15 2013-06-12 南京师范大学 Method for preparing hawthorn yogurt being rich in angiotensin-converting enzyme inhibition peptides

Also Published As

Publication number Publication date
US20150374021A1 (en) 2015-12-31
JP2019058184A (en) 2019-04-18
US20200281236A1 (en) 2020-09-10
US11540539B2 (en) 2023-01-03
DK2953934T3 (en) 2018-05-28
CA2900710A1 (en) 2014-08-14
EP3732994B1 (en) 2022-11-09
EP3366677B1 (en) 2020-09-09
CA2900707C (en) 2021-07-27
CA2900707A1 (en) 2014-08-14
EP3466930A1 (en) 2019-04-10
CN108902893A (en) 2018-11-30
BR112015018847A2 (en) 2017-07-18
CN105189460B (en) 2021-03-09
PT2956440T (en) 2018-05-08
DK3732994T3 (en) 2022-12-05
EP2954037B1 (en) 2018-04-11
EP2954037A1 (en) 2015-12-16
WO2014124198A1 (en) 2014-08-14
EP2953934B1 (en) 2018-04-11
CN105164245A (en) 2015-12-16
DK3466930T3 (en) 2022-09-05
PT3732994T (en) 2022-12-02
BR112015018948A2 (en) 2017-07-18
US10159268B2 (en) 2018-12-25
DK2954037T3 (en) 2018-05-28
CA3081195C (en) 2022-06-21
JP2022027792A (en) 2022-02-14
EP3732994A1 (en) 2020-11-04
FI3732994T3 (en) 2023-01-13
PT2984073T (en) 2019-01-21
DK3366677T3 (en) 2020-09-28
EP2956440A1 (en) 2015-12-23
DK2956440T3 (en) 2018-05-28
US20150342233A1 (en) 2015-12-03
EP2956440B1 (en) 2018-04-11
WO2014124216A1 (en) 2014-08-14
ES2831028T3 (en) 2021-06-07
JP2024045277A (en) 2024-04-02
CN105164245B (en) 2018-05-22
PT3466930T (en) 2022-08-19
JP7188999B2 (en) 2022-12-13
PT3366677T (en) 2020-11-03
JP2019193663A (en) 2019-11-07
WO2014124212A1 (en) 2014-08-14
WO2014124193A1 (en) 2014-08-14
ES2671954T3 (en) 2018-06-11
WO2014124220A1 (en) 2014-08-14
ES2936634T3 (en) 2023-03-21
DK2984073T3 (en) 2019-01-21
ES2704880T3 (en) 2019-03-20
WO2014124207A1 (en) 2014-08-14
WO2014124209A1 (en) 2014-08-14
WO2014124219A1 (en) 2014-08-14
EP3366677A1 (en) 2018-08-29
PT2953934T (en) 2018-05-08
WO2014124214A1 (en) 2014-08-14
JP6982599B2 (en) 2021-12-17
EP2984073B1 (en) 2018-10-24
ES2925071T3 (en) 2022-10-13
WO2014124205A1 (en) 2014-08-14
CN111557432A (en) 2020-08-21
CN111557432B (en) 2023-08-04
JP2016506747A (en) 2016-03-07
PT2954037T (en) 2018-07-03
CA3081195A1 (en) 2014-08-14
WO2014124222A1 (en) 2014-08-14
CN108902893B (en) 2022-02-25
CN105189460A (en) 2015-12-23
JP2016509830A (en) 2016-04-04
WO2014124201A1 (en) 2014-08-14
EP2984073A1 (en) 2016-02-17
EP3466930B1 (en) 2022-07-20
WO2014124191A1 (en) 2014-08-14
EP2953934A1 (en) 2015-12-16
US20190090520A1 (en) 2019-03-28
ES2675215T3 (en) 2018-07-09
CA2900710C (en) 2023-08-08

Similar Documents

Publication Publication Date Title
ES2675018T3 (en) Sodium Reduced Food Products
WO2020033669A8 (en) Antagonists of t2r54 and compositions and uses thereof
EA200702421A1 (en) SUBSTITUTED BY GASOLINE SERIN-AMIDA
MY159705A (en) Plant disease control composition and method for controlling plant disease by applying the same
RU2011144143A (en) PEPTIDE USE FOR GIVING KOKUMI
SG160335A1 (en) Heterocyclic compounds as sweetener enhancers
WO2018005806A3 (en) Methods and microorganisms for producing flavors and fragrance chemicals
EA201000997A1 (en) TEA COMPOSITION AND METHOD FOR ITS PRODUCTION
WO2009095798A3 (en) Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
CN106235293A (en) A kind of Wasabia japonic (Euterma Wasabi) barbecue sauce and preparation method thereof
MX2022000996A (en) Novel steviol glycoside, method for producing same, and sweetener composition containing same.
DE602006015630D1 (en) Thiole als aromastoffe
CN102775518A (en) Chitosan succinate flavor enhancer
KR20110040060A (en) Process for the preparation of salted anchovy containing rubus coreanus miquel and salted anchovy containing rubus coreanus miquel prepared therefrom
JP2015133951A (en) Method for manufacturing fried food using deep ocean water
WO2017186973A3 (en) Blends containing enantiomerically pure ambrocenide®
CN104450309A (en) Non-toxic cleaning agent
BRPI0606385A2 (en) method for imparting, accentuating, ameliorating or modifying the flavor or taste properties of a flavoring composition or a flavored article, composite, composite flavoring composition, and flavored article
CN102775521A (en) Chitosan guanylate flavor enhancer
Kan et al. Essential oil yield and compositions of endemic mountain tea (Sideritis libanotica Labill. ssp. linearis (Bentham) Borm. and Sideritis bilgerana PH Davis) cultivated in Konya ecological conditions of Turkey
DE60302607D1 (en) Composition for the treatment of whole muscle product and process for the preparation of a whole muscle product with this composition
CN102775522B (en) Chitosan inosine silicate flavoring agent
MX340335B (en) Organic compounds.
JP2010528631A (en) Salty taste enhancement
KR20070112319A (en) Method for preparing red radish pickle